In the news: Drug discovery startup based on U of A research receives $4 million seed funding
Wednesday
Image
Curtis Thorne, PhD, assistant professor, cellular and molecular medicine, and one of his doctoral students, Carly R. Cabel.
Cancer center members Christopher Hulme, PhD, professor of medicinal chemistry at the R. Ken Coit College of Pharmacy, and Curtis Thorne, PhD, associate professor of cellular and molecular medicine at the College of Medicine – Tucson, recently received $4 million in venture funding to develop drugs that are orally bioavailable, well-tolerated and versatile in treating multiple cancer types.